Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

ADMA Biologics Company Profile (NASDAQ:ADMA)

Consensus Ratings for ADMA Biologics (NASDAQ:ADMA) (?)
Ratings Breakdown: 2 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $15.50 (51.22% upside)

Analysts' Ratings History for ADMA Biologics (NASDAQ:ADMA)
Show:
DateFirmActionRatingPrice TargetDetailsShare
7/11/2014Maxim GroupReiterated RatingPositive -> Buy$15.00ViewTweet This Rating  Share This Rating on StockTwits
12/2/2013Maxim GroupInitiated CoverageBuy$15.00ViewTweet This Rating  Share This Rating on StockTwits
11/18/2013Ladenburg ThalmannInitiated CoverageBuy$16.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 9/30/2012 forward)
Discuss ADMA Biologics